Amylin Pharmaceuticals
Karen Adam has extensive work experience in the pharmaceutical industry. Karen began their career at Pfizer La Jolla in 1999 as a Director of Quality. Karen then spent some time at SkyePharma as a Sr. Director of Quality from 2002 to 2004. In 2006, they joined Amylin Pharmaceuticals as a Sr. Director of Quality Compliance and later became the Director of Quality Compliance. In 2008, Karen Adam moved to Amylin Pharmaceuticals, a subsidiary of Astra Zeneca, where they held the position of Sr. Director of Quality until 2014.
Karen Adam attended the University of Wisconsin-Madison from 1974 to 1978. No specific degree or field of study information is available.
Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.Develops a line of diagnostic and therapeutic products for diabetics.Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside thebox". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.